Dirk Van de Put to Become CEO of Mondelēz International as Long-time CEO Irene Rosenfeld Retires
Aug 02, 2017 11:00 am UTC| Business
Transition Effective November 2017Rosenfeld to Continue as Chairman until March 31, 2018 DEERFIELD, Ill., Aug. 02, 2017 -- Mondelēz International (NASDAQ:MDLZ) today announced that its Board of Directors has...
Mondelēz International Reports Q2 Results and Increases Quarterly Dividend
Aug 02, 2017 11:00 am UTC| Business
Operating income margin was 10.7%, up 60 basis points; Adjusted Operating Income1 margin was 15.8%, up 90 basis pointsDiluted EPS was $0.32, up 10%; Adjusted EPS1 was $0.48, up 19% on a constant-currency basisNet revenues...
Aug 02, 2017 11:00 am UTC| Business
New York, Aug. 02, 2017 -- PeerIQ, a leading provider of data and analytics for the lending sector, today announced that it has closed a $12 million Series A funding round, co-led by TransUnion, Hearst’s Financial...
SynTech Bioenergy Announces Japan Distributorship
Aug 02, 2017 11:00 am UTC| Business
DENVER, Aug. 02, 2017 -- SynTech Bioenergy, a Denver-based renewable energy technology company, has officially announced the formation of its Japanese Distributorship in Tokyo, Japan under the name SynTech Japan Co,...
Manhattan Bridge Capital, Inc. Declares Quarterly Dividend
Aug 02, 2017 11:00 am UTC| Business
GREAT NECK, N.Y., Aug. 02, 2017 -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that its board of directors has authorized a quarterly dividend of $0.1025 per share to be paid to all shareholders of...
Cyclacel Pharmaceuticals to Release Second Quarter 2017 Financial Results
Aug 02, 2017 11:00 am UTC| Business
BERKELEY HEIGHTS, N.J., Aug. 02, 2017 -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...
Nabriva Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference
Aug 02, 2017 11:00 am UTC| Business
DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 02, 2017 -- Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the research and development of new medicines to treat serious infections, with a...
AIs encode language like brains do − opening a window on human conversations